BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26

• FDA

  FDA Approves Gilead Sciences, Inc.'s (JOBS) Cayston(R) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa

  February 23, 2010

   · 

  8 min read
• Drug Development

  Genentech (South SF)'s (JOBS) Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint

  February 23, 2010

   · 

  10 min read
• Pharm Country

  OrbiMed Launches $550 Million Venture Capital Fund

  February 23, 2010

   · 

  2 min read
• Business

  Solta Medical, Inc. Reports Fourth Quarter and Full Year 2009 Results Provides Financial Goals for 2010

  February 23, 2010

   · 

  7 min read
• FDA

  Instrumentation Laboratory Company Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay

  February 23, 2010

   · 

  3 min read
• Genetown

  Inverness Medical Innovations, Inc. Launches Follow-Up Tender Offer for Additional Shares of Standard Diagnostics

  February 23, 2010

   · 

  2 min read
• Business

  Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International

  February 23, 2010

   · 

  2 min read
• Drug Development

  Allon Therapeutics, Inc. Presents Peripheral Neuropathy Preclinical Efficacy Data For AL-309

  February 23, 2010

   · 

  5 min read
• BioCapital

  Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Genetically Attenuated Whole Parasite Malaria Vaccine

  February 23, 2010

   · 

  1 min read
• Policy

  Ark Therapeutics Files Cerepro(R) Re-Examination Documentation With The European Medicines Evaluation Agency

  February 23, 2010

   · 

  3 min read